Prediction of prostate cancer aggressiveness using 18F-Fluciclovine (FACBC) PET and multisequence mu...
Prediction of prostate cancer aggressiveness using 18F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI
About this item
Full title
Author / Creator
Movahedi, Parisa , Merisaari, Harri , Perez, Ileana Montoya , Taimen, Pekka , Kemppainen, Jukka , Kuisma, Anna , Eskola, Olli , Teuho, Jarmo , Saunavaara, Jani , Pesola, Marko , Kähkönen, Esa , Ettala, Otto , Liimatainen, Timo , Pahikkala, Tapio , Boström, Peter , Aronen, Hannu , Minn, Heikki and Jambor, Ivan
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
The aim of this prospective single-institution clinical trial (NCT02002455) was to evaluate the potential of advanced post-processing methods for
18
F-Fluciclovine PET and multisequence multiparametric MRI in the prediction of prostate cancer (PCa) aggressiveness, defined by Gleason Grade Group (GGG). 21 patients with PCa underwent PET/CT, PE...
Alternative Titles
Full title
Prediction of prostate cancer aggressiveness using 18F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7287051
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7287051
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-020-66255-8
